Skip to main content
Livermore
Livermore
ZHEN

Alliancebernstein L.P.

SEC CIK
0001109448
Latest filing
Aug 14, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Alliancebernstein L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of APLS by Alliancebernstein L.P., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−638,291−100.0%Sold outHolders
Q1 2026638,291$16.0M<0.1%+603,761+1,748.5%AddedHolders
Q4 202534,530$867.4K<0.1%−46,075−57.2%ReducedHolders
Q3 202580,605$1.82M<0.1%+48,676+152.5%AddedHolders
Q2 202531,929$552.7K<0.1%−12,983−28.9%ReducedHolders
Q1 202544,912$982.2K<0.1%+13,572+43.3%AddedHolders
Q4 202431,340$1.00M<0.1%−9,678−23.6%ReducedHolders
Q3 202441,018$1.18M<0.1%+9,196+28.9%AddedHolders
Q2 202431,822$1.22M<0.1%+409+1.3%AddedHolders
Q1 202431,413$1.85M<0.1%+857+2.8%AddedHolders
Q4 202330,556$1.83M<0.1%+1,084+3.7%AddedHolders
Q3 202329,472$1.12M<0.1%−135−0.5%ReducedHolders
Q2 202329,607$2.70M<0.1%−81,493−73.4%ReducedHolders
Q1 2023111,100$7.33M<0.1%00.0%UnchangedHolders
Q4 2022111,100$5.74M<0.1%−41,824−27.3%ReducedHolders
Q3 2022152,924$10.4M<0.1%−11,517−7.0%ReducedHolders
Q2 2022164,441$7.44M<0.1%−14,229−8.0%ReducedHolders
Q1 2022178,670$9.08M<0.1%+98,670+123.3%AddedHolders
Q4 202180,000$3.78M<0.1%+800+1.0%AddedHolders
Q3 202179,200$2.61M<0.1%−900−1.1%ReducedHolders
Q2 202180,100$5.06M<0.1%00.0%UnchangedHolders
Q1 202180,100$3.44M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.